ICW Investment Advisors’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-1,014
Closed -$355K 149
2025
Q4
$355K Sell
1,014
-1
-0.1% -$338 0.13% 129
2025
Q3
$328K Hold
1,015
0.12% 131
2025
Q2
$395K Sell
1,015
-1
-0.1% -$402 0.16% 125
2025
Q1
$442K Buy
1,016
+1
+0.1% +$401 0.18% 119
2024
Q4
$375K Buy
+1,015
New +$425K 0.16% 126

Other funds holding ELV

ICW Investment Advisors's ELV Position: Q1 2026 in Review

ICW Investment Advisors sold out of Elevance Health (ELV) in Q1 2026, closing a stake of 1,014 shares — an estimated $355K sold.

ICW Investment Advisors first reported a position in ELV in Q4 2024 and held it in 5 quarters. The position peaked at $442K in Q1 2025. 1,462 funds tracked by Wall St. Rank hold ELV as of Q1 2026.

  • ICW Investment Advisors reported no remaining Elevance Health position as of Q1 2026 after selling out during the quarter.
  • ICW Investment Advisors sold 1,014 Elevance Health shares in Q1 2026, an estimated $355K.
  • ICW Investment Advisors first reported a position in Elevance Health in Q4 2024 and held it in 5 quarters.
  • ICW Investment Advisors's Elevance Health position peaked at $442K in Q1 2025.
  • 1,462 funds tracked by Wall St. Rank held Elevance Health as of Q1 2026.

Based on ICW Investment Advisors's 13F filing for Q1 2026, filed 11 May 2026.